1 week Ago By Defense World Staff
Investment analysts at StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals ( NASDAQ:CPIX – Get Free Report ) in a research note issued to investors on Sunday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Trading Up 3.1 % NASDAQ CPIX opened at $2.30 on Friday.
Cumberland Pharmaceuticals has a 52 week low of $1.04 and a 52 week high of $3.05.
The firm has a 50 day moving average of $1.62 and a two-hundred day moving average of $1.46.
The company has a quick ratio of 0.99, a current ratio of 1.13 and a debt-to-equity ratio of 0.
41. The stock has a market capitalization of $32.30 million, a PE ratio of -2.
99 and a beta of 0.13. Cumberland Pharmaceuticals Company Profile ( Get Free Report ) Featured Articles Five stocks we like better than Cumberland Pharmaceuticals Investing In Automotive Stocks Quantum Opportunity: Skywater Technology’s Long-Term Potential What is the Hang Seng index? Nebius Group: The Rising Star in AI Infrastructure Consumer Staples Stocks, Explained MarketBeat Week in Review – 12/30 – 1/03 Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.
com's FREE daily email newsletter ..
